Gender heterogeneity in dyslipidemia prevalence, trends with age and associated factors in middle age rural Chinese.

Lipids in Health and Disease
Minmin WangYang Ke

Abstract

Heterogeneity should be carefully addressed to facilitate establishment of effective population-level blood lipid management. The primary aim of the study was to investigate gender heterogeneity in prevalence of dyslipidemia, including trends with age and associated factors in middle age rural Chinese. This is a cross-sectional study based on a baseline investigation of a population-based randomized controlled trial in rural China, involving 26,378 permanent residents of age 45-69. The age-specific prevalence of dyslipidemia was estimated for men and women, and the trends of prevalence with age were compared. Logistic regression was used to explore the factors associated with prevalent risk of dyslipidemia. The overall prevalence of dyslipidemia was significantly higher in females than in males for borderline high and above (BHA) total cholesterol (TC ≥ 200 mg/dL), BHA triglycerides (TG ≥ 150 mg/dL) and BHA low-density lipoprotein cholesterol (LDL-C ≥ 130 mg/dL), but was lower for low high-density lipoprotein cholesterol (HDL-C < 40 mg/dL) in females than the corresponding prevalence in males. The prevalence of borderline high and above TC, TG and LDL-C all rose with age in females, but was stable or even decreased with age in ...Continue Reading

References

Dec 1, 1986·Journal of the American College of Cardiology·P L CannerW Friedewald
Jan 1, 1994·Drugs·J Shepherd
May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
Jun 27, 2002·The American Journal of Cardiology·Michael E Mendelsohn
Nov 7, 2007·The New England Journal of Medicine·Philip J BarterUNKNOWN ILLUMINATE Investigators
Nov 27, 2007·International Journal of Cardiology·Guilherme Figueiredo MarquezineJosé G Mill
Nov 12, 2009·JAMA : the Journal of the American Medical Association·UNKNOWN Emerging Risk Factors CollaborationJohn Danesh
Feb 9, 2010·Trends in Pharmacological Sciences·Andrea CignarellaChiara Bolego
Nov 2, 2011·Journal of Atherosclerosis and Thrombosis·Li CaiPeiyu Wang
Apr 12, 2012·Circulation·Wenying YangUNKNOWN China National Diabetes and Metabolic Disorders Study Investigators
Nov 7, 2012·The New England Journal of Medicine·Gregory G SchwartzUNKNOWN dal-OUTCOMES Investigators
Mar 19, 2013·Journal of Diabetes and Metabolic Disorders·Zahra JouyandehMojgan Asadi
Apr 16, 2014·BioMed Research International·Fernando Lizcano, Guillermo Guzmán
May 13, 2014·PloS One·Shashank R JoshiUNKNOWN ICMR-INDIAB Collaborative Study Group
May 21, 2014·Best Practice & Research. Clinical Endocrinology & Metabolism·Barry A FranklinR James Barnard
Aug 19, 2014·Lancet·Daniel J Rader, G Kees Hovingh
Aug 19, 2014·Lancet·Børge G Nordestgaard, Anette Varbo
Dec 17, 2014·Lipids in Health and Disease·Guo-Zhe SunYing-Xian Sun
Jul 15, 2015·Lipids in Health and Disease·Wen-Qing NiJian Xu
Oct 31, 2015·International Journal of Environmental Research and Public Health·Li QiYulin Wang
Mar 16, 2016·Atherosclerosis·Ling PanUNKNOWN China National Survey of Chronic Kidney Disease Working Group
May 24, 2017·European Heart Journal Supplements : Journal of the European Society of Cardiology·Chen WeiweiHu Shengshou
Mar 13, 2019·Nature Medicine·Luanluan SunUNKNOWN Regional Co-ordinating Centres

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT01688908

Software Mentioned

STATA

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.